# Machine Medicine Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/machine-medicine-technologies

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.machinemedicine.com
- Total disclosed funding: $4.1M
- Latest round: Seed (Sep 22, 2022)
- Investors on record: 2

## About

Machine Medicine Technologies Ltd develops advanced motor assessment technologies that enhance understanding and application of bioelectric medicine, catering to healthcare providers and rehabilitation institutions.Founded in 2017 and headquartered in London, UK, Machine Medicine Technologies Ltd focuses on creating innovative solutions for motor assessments in healthcare. The company has successfully completed four deals, with its most recent funding round occurring on September 22, 2022. In this Seed round, Machine Medicine raised GBP 2 million from SOSV, bringing the total amount raised to GBP 2 million and valuing the company at GBP 15.63 million post-money. CEO Jonathan O'Keeffe has steered the company through these pivotal funding stages, although no prior company founding history is noted.Machine Medicine specializes in advanced motor assessment technologies designed to enhance the understanding of bioelectric medicine. The company's core offerings include innovative assessment tools that leverage bioelectric signals to personalize treatment and improve motor function outcomes. These products are aimed at healthcare professionals, rehabilitation centers, and research institutions, enabling better assessments of motor capabilities and tailored interventions. By focusing on data-driven personalization, Machine Medicine addresses critical challenges in motor rehabilitation and performance optimization, with its products marketed primarily in North America and Europe.Machine Medicine operates under a B2B model, engaging directly with healthcare providers and institutions to deliver its motor assessment solutions. Revenue is generated through structured partnerships and subscription plans, providing ongoing access to technologies and data analytics services. Their flagship products include tiered pricing plans that enable clients to select options aligned with their operational needs and budgets. These offerings may include enhanced service packages that provide comprehensive data insights and software updates, fostering long-term client relationships and establishing Machine Medicine as a key player in the bioelectric medicine landscape.In September 2022, Machine Medicine Technologies Ltd raised GBP 2 million in Seed funding, which will be utilized to support the development of new products and enhance existing technologies. The company is targeting expansion into North America and Europe by 2023, aiming to reach additional healthcare markets. The recent funding will facilitate these initiatives, ensuring the company remains competitive in the bioelectric medicine sector.

## Funding rounds

- Seed, Sep 22, 2022, $2.2M — SOSV
- Seed, May 25, 2020, $0.5M — SOSV, RebelBio
- Seed, Apr 3, 2019, $1.5M — SOSV, RebelBio
- Seed, Aug 15, 2018 — SOSV, RebelBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- RebelBio — Seed